Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.

Cancer letters - 20 Mar 2003

Hara Yasuo, Zheng Zuoyu, Evans Susan C, Malatjalian Dickran, Riddell D Christie, Guernsey Duane L, Wang Li Dong, Riabowol Karl, Casson Alan G

Abstract excerpt

The aim of this study was to characterize molecular alterations of the recently reported candidate tumor suppressor gene, ING1, and to explore the relationship between ING1 and p53 in a well-defined series of adenocarcinomas of the esophagogastric junction (AdEGJ). Polymerase chain reaction (PCR)-based assays were used to characterize ING1 and p53 alterations, relative to histologically normal esophageal mucosa....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Cell Cycle Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Genes, Tumor Suppressor

Share to Intracellular Signaling Peptides and Proteins

Share to Polymorphism, Single-Stranded Conformational

Share to Proteins

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 12637159
DOI: 10.1016/s0304-3835(02)00635-3

Genes

ING1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.PMID 12637159Read ↗

Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.Semantic proximity Read ↗

No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.Semantic proximity Read ↗

Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.Semantic proximity Read ↗

A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma.Semantic proximity Read ↗

Cyclin D1 Guanine/Adenine 870 Polymorphism With Altered Protein Expression Is Associated With Genomic Instability and Aggressive Clinical Biology of Esophageal AdenocarcinomaSemantic proximity Read ↗

Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.Semantic proximity Read ↗

Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.Semantic proximity Read ↗

p53 gene mutations in Barrett's epithelium and esophageal cancer.Semantic proximity Read ↗

Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.Semantic proximity Read ↗

[Mutation, loss of heterozygosity, and expression of tumor suppressor gene ING1 in sporadic colorectal carcinoma].Semantic proximity Read ↗

Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53.Semantic proximity Read ↗

Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.